NCM
EGRX

Nantahala Capital Management’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History

Nantahala Capital Management’s Portfolio EGRX Stock Details EGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-2,356,536
Closed -$8.79M – 143
2024
Q3 		$8.79M Buy
2,356,536
+394,466
+20% +$1.47M 0.44% 35
2024
Q2 		$11M Buy
1,962,070
+703,308
+56% +$3.94M 0.64% 27
2024
Q1 		$6.6M Buy
+1,258,762
New +$6.6M 0.38% 43